Screening for Depression and Suicide Risk in Children and Adolescents

2022206 citationsReviewbronze Open Access

Authors

US Preventive Services Task Force · University of California, Los Angeles

Carol M. Mangione · Harvard University

Michael J. Barry · University of North Carolina at Chapel Hill

Wanda K. Nicholson · University of North Carolina at Chapel Hill

Michael D. Cabana · Albert Einstein College of Medicine

David Chelmow · Virginia Commonwealth University

Tumaini R. Coker

Abstract

The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children 11 years or younger. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in children and adolescents. (I statement).

Topics & Keywords

Child and Adolescent Psychosocial and Emotional Development Suicide and Self-Harm Studies Adolescent and Pediatric Healthcare

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 328, Issue 15, pp. 1534-1534

DOI: 10.1001/jama.2022.16946

Field-Weighted Citation Impact: 37.37